For the first time in its 75-year history, the maximum cost of general scripts under the Pharmaceutical Benefits Scheme (PBS) will fall. Under a Bill
The Pharmaceutical Society of Australia (PSA) welcomes the national rollout of the Take Home Naloxone (THN) program, which allows pharmacists to provide free naloxone from
Finding the right type of contraception is important. Oral contraception – also known as The Pill – is the most popular and widely used method.
NPS MedicineWise welcomes the commitment from Labor to review a decision announced in the budget that affects the way quality use of medicines (QUM) is
NPS MedicineWise is calling for a review of the decision, announced in the Federal Budget, to change the way Quality Use of Medicines (QUM) initiatives
A new survey released today asked people what they know about the side effects of medicine. Falls, confusion, trouble remembering and concentrating. Also dry mouth,
Dr Vince Polito, a clinical psychologist and Senior Research Fellow at Macquarie University’s School of Psychological Sciences, is leading a clinical trial to test the
Britain will now expand access to Pfizer’s oral antiviral COVID-19 treatment to thousands more people by adding it to a trial to assess how best
Australians with paroxysmal nocturnal haemoglobinuria (PNH)—a condition that produces defective blood cells—will have access to a new treatment through the Pharmaceutical Benefits Scheme (PBS). PNH
Civica Care, an Australian leader in innovative software for community care organisations, is helping the Aged Care industry across Australia through their Carelink Suite software.